AllTest SARS-CoV-2 / Influenza A+B / RSV / Adenovirus / M.pneumoniae antigen combo rapid test
The AllTest SARS-CoV-2 / Influenza A+B / RSV / Adenovirus / M.pneumoniae antigen combo rapid test is intended for the qualitative detection of antigens from SARS-CoV-2, Influenza A, Influenza B, RSV, Adenovirus, and Mycoplasma pneumoniae in nasopharyngeal swab specimens. For professional in vitro diagnostic use.
Generally
The AllTest SARS-CoV-2/ Influenza A+B/ RSV/ Adenovirus/ M.pneumoniae antigen combo rapid test provides a comprehensive solution for the rapid detection of multiple respiratory pathogens from a single test. This easy-to-use test delivers accurate results in just 15 minutes, supporting timely clinical decision-making and infection control. Ideal for use in point-of-care settings, clinics, and hospitals.
AllTest SARS-CoV-2/ Influenza A+B/ RSV/ Adenovirus/ M.pneumoniae antigen combo rapid test offers
- Simple test procedure
- Multiple respiratory pathogens from a single test
- Clear color reaction for easy interpretation of results
- Accurate results in 15 minutes
- Internal procedural control
Technical data
| Products available | AllTest SARS-CoV-2 / Influenza A+B / RSV / Adenovirus / M.pneumoniae Antigen Combo Rapid Test, 20 T (product no IRT- 555, order no 155505) |
| Use | For professional in vitro diagnostics |
| Method | Chromatographic immunoassay |
| Sample type | Nasopharyngeal swab |
| Instrument information | Not required (visual read) |
| Time to result | 15 minutes |
| Reading of the result | Visual (color change) |
| Storage | 2-30°C |
| Sensitivity |
|
| Specificity |
|
| Transportation | Room temperature, avoid freezing |
| Registered trademark | AllTest is a registered trademark owned by Hangzhou AllTest Biotech Co., Ltd. |
More information
Read more: HANGZHOU ALLTEST BIOTECH CO., LTD